🇺🇸 Lactobacillus Plantarum 299v in United States

11 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Bone Marrow Transplant — 2 reports (18.18%)
  2. Asthenia — 1 report (9.09%)
  3. Cytomegalovirus Infection Reactivation — 1 report (9.09%)
  4. Diarrhoea — 1 report (9.09%)
  5. Eye Discharge — 1 report (9.09%)
  6. Graft Versus Host Disease — 1 report (9.09%)
  7. Hypersomnia — 1 report (9.09%)
  8. Hypophagia — 1 report (9.09%)
  9. Nausea — 1 report (9.09%)
  10. Rash — 1 report (9.09%)

Source database →

Lactobacillus Plantarum 299v in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Lactobacillus Plantarum 299v approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Lactobacillus Plantarum 299v in United States?

Medical University of Bialystok is the originator. The local marketing authorisation holder may differ — check the official source linked above.